These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 944061)

  • 1. Proceedings: Stereospecific suppression by opiates of the quasi-morphine abstinence syndrome elicited by 3-isobutyl-l-methylxanthine (IBMX).
    Collier HO; Francis DL
    Br J Pharmacol; 1976 Mar; 56(3):382P. PubMed ID: 944061
    [No Abstract]   [Full Text] [Related]  

  • 2. Opiates, cyclic nucleotides, and xanthines.
    Collier HO; Francis DL; Roy AC
    Adv Biochem Psychopharmacol; 1976; 15():337-45. PubMed ID: 192053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Character and meaning of quasi-morphine withdrawal phenomena elicited by methylxanthines.
    Collier HO; Cuthbert NJ; Francis DL
    Fed Proc; 1981 Apr; 40(5):1513-8. PubMed ID: 6163662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphine blocks and naloxone enhances suppression of operant behavior by low doses of 3-isobutyl-1-methylxanthine.
    Kleven MS; Sparber SB
    J Pharmacol Exp Ther; 1989 Jan; 248(1):273-7. PubMed ID: 2464058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of precipitated abstinence in methadone-dependent rats by delta 9-THC.
    Hine B; Torrelio M; Gershon S
    Psychopharmacol Commun; 1975; 1(3):275-83. PubMed ID: 1241452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azidomorphine: subjective effects and suppression of morphine abstinence.
    Clark SC; Jasinski DR; Pevnick JS; Griffith JD
    Clin Pharmacol Ther; 1976 Mar; 19(3):295-9. PubMed ID: 1261168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification by disulfiram or methyltyrosine methylester (H 44-68) of abstinence symptoms in morphine-tolerant rats.
    Mattila MJ; Alhava E; Mansner R
    Arzneimittelforschung; 1968 Sep; 18(9):1163-6. PubMed ID: 5755932
    [No Abstract]   [Full Text] [Related]  

  • 8. Quantitative aspects of precipitated abstinence in morphine-dependent rats.
    Wei E; Loh HH; Way EL
    J Pharmacol Exp Ther; 1973 Feb; 184(2):398-403. PubMed ID: 4734580
    [No Abstract]   [Full Text] [Related]  

  • 9. [The action of low doses of bromocryptin in experimental morphine abstinence in rats].
    Stanishevskaia AV; Khristoliubova NA; Vekshina NL; Varfolomeev SO; Anokhina IP
    Farmakol Toksikol; 1991; 54(3):15-7. PubMed ID: 1655521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative stimulus effects of morphine withdrawal in the dependent rat: suppression by opiate and nonopiate drugs.
    Holtzman SG
    J Pharmacol Exp Ther; 1985 Apr; 233(1):80-6. PubMed ID: 4039002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The short- and long-termed effects of beta-endorphin on the opiate abstinence syndrome in rats.
    Haracz JL; Tseng LF
    Commun Psychopharmacol; 1980; 4(3):219-24. PubMed ID: 6262008
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of psychotropic agents on the manifestation of the morphine abstinence syndrome in mice].
    Patkina NA; Evartau EE
    Farmakol Toksikol; 1980; 43(1):19-23. PubMed ID: 7189719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma malondialdehyde levels and opiate withdrawal signs observed in rats treated with morphine plus naloxone: effects of alpha-lipoic acid administration.
    Pinelli A; Cighetti G; Trivulzio S
    Fundam Clin Pharmacol; 2008 Aug; 22(4):439-45. PubMed ID: 18705754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decline in the mean integrated electroencephalogram voltage during morphine abstinence in the rat.
    Khazan N; Colasanti B
    J Pharmacol Exp Ther; 1971 Jun; 177(3):491-9. PubMed ID: 4328019
    [No Abstract]   [Full Text] [Related]  

  • 15. [Activity of naloxone and naltrexone on the development of the morphine withdrawal syndrome].
    Piccinelli D; de Feo G; Mazzanti G
    Boll Soc Ital Biol Sper; 1986 Oct; 62(10):1221-8. PubMed ID: 3828120
    [No Abstract]   [Full Text] [Related]  

  • 16. In vivo and in vitro studies with agents that cause quasi-morphine withdrawal syndromes.
    Sheldon RJ; Cowan A
    Life Sci; 1982 Oct 18-25; 31(16-17):1699-702. PubMed ID: 6185813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and chronic effects of morphine and withdrawal from morphine on temperature in the cat.
    French ED; Vasquez SA; George R
    Proc West Pharmacol Soc; 1976; 19():273-7. PubMed ID: 1033555
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effect of GABA-positive agents on the formation of morphine dependence and on the manifestations of a withdrawal syndrome].
    Belozertseva IV; Andreev BV
    Eksp Klin Farmakol; 2000; 63(1):19-23. PubMed ID: 10763104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphine pellet implantation in rats: quantitative assessment of tolerance and dependence.
    Cicero TJ; Meyer ER
    J Pharmacol Exp Ther; 1973 Feb; 184(2):404-8. PubMed ID: 4734581
    [No Abstract]   [Full Text] [Related]  

  • 20. Brain sites of precipitated abstinence in morphine-dependent rats.
    Wei E; Loh HH; Way EL
    J Pharmacol Exp Ther; 1973 Apr; 185(1):108-15. PubMed ID: 4735025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.